China News Service, Beijing, October 17 (Reporter Li Yanan) In order to facilitate early diagnosis and treatment and advance the prevention and treatment of breast cancer, the "Health Management of Breast Cancer Patients in China" pink ribbon prevention and control science campaign is being carried out nationwide.
The Secretary-General of the National Cancer Center Breast Cancer Screening and Early Diagnosis and Treatment Standards Committee, and Professor Ma Fei from the Cancer Hospital of the Chinese Academy of Medical Sciences recently called on the female compatriots to care for their health, regular self-examinations, and detailed high-risk breast cancer Factors, breast cancer diagnosis methods suitable for Chinese women.
Every October is International Breast Cancer Care Month.
The "Health Management for Breast Cancer Patients in China" Pink Ribbon Prevention and Control Science Action is sponsored by the National Cancer Center for Quality Control Breast Cancer Expert Committee, China Cancer Foundation, Beijing Breast Cancer Prevention and Treatment Association, China Health Management Association Health Communication Branch, and the social welfare organization Lohas Organized by the alliance, supported by Hengrui Medicine.
As the highlight of the special operation that lasted throughout the month, a live broadcast of breast cancer science popularization by well-known breast cancer experts and internet celebrities in the United Nations was recently held in Beijing.
The live broadcast aims to popularize all-round and full-cycle breast cancer prevention knowledge for the general public and patients, and calls on the public to care for breast cancer patients.
According to reports, breast cancer is the most common malignant tumor in Chinese women. The incidence of breast cancer in Chinese women is 42.55 per 100,000. It is estimated that by 2021, there will be 2.5 million breast cancer patients.
According to statistics, 81.4% of women in China have insufficient knowledge about breast cancer, and the early diagnosis rate of breast cancer is less than 30%. Many women have missed the best time for treatment when they are diagnosed with breast cancer.
Although the 5-year survival rate of breast cancer patients in China has increased to 83.2%, there is still a gap compared with developed countries.
The low early detection rate is one of the important reasons.
In particular, HER2-positive breast cancer, which has the highest recurrence rate and mortality rate among all types of breast cancer, needs more attention.
Professor Ma Fei mentioned in the live broadcast: “According to the national strategic deployment of the'Healthy China 2030', to complete the task of increasing the 5-year survival rate of cancer by 15% by 2030, it is necessary to move the threshold of cancer prevention and treatment forward, and do a good job in breast cancer treatment. Early detection, early diagnosis, and early treatment of people at high risk of cancer. At the same time, we should do a good job of education for healthy people to reduce the incidence rate and achieve effective prevention." He called on women to care for their health, conduct regular self-examinations, and introduced the high risk of breast cancer. Risk factors, breast cancer diagnosis methods suitable for Chinese women, comprehensive multidisciplinary treatment of breast cancer patients, comprehensive rehabilitation, interdisciplinary health management and other scientific knowledge of breast cancer prevention and treatment.
Professor Ma Fei said: "The Pink Ribbon Prevention and Control Action of "Health Management for Breast Cancer Patients in China" hosted during the International Breast Cancer Care Month is to implement the concept of breast cancer health management of'all-round improvement and full-cycle promotion'. In cancer prevention, diagnosis, treatment, rehabilitation and other links, systematic breast cancer science education is carried out for the majority of female compatriots and patients. In recent years, with the continuous improvement of global medical technology, advanced breast cancer patients, especially HER2-positive breast cancer patients In addition to internationally imported targeted drugs, China’s domestically developed oral targeted drugs have also been proven in many clinical studies to benefit patients with HER2-positive breast cancer, and HER2-positive advanced breast Cancer achieves long-term survival and even clinical cure is within reach. Not only that, the more complete patient whole-course management model has promoted the survival benefits of patients with advanced breast cancer in China, and greatly improved the quality of life and life cycle of patients. Hope through This popular science action will increase patients’ awareness and confidence in scientific response to diseases, and work together to increase the cure rate."
Liu Hehong, the rotating chairman of the Lohas Alliance, the organizer of the event, said that breast cancer patients must not only live long, but also live well.
Improved lifestyle and appropriate psychological intervention can effectively reduce the risk of death and recurrence of breast cancer patients and improve the quality of life.
The one-month disease science topics covered "breast health and breast cancer prevention", "breast cancer patient image management and psychosocial psychology", "long-term symptom management during breast cancer treatment", "diet and exercise for breast cancer patients", etc. content.
As of October 16, the pink ribbon prevention and control science campaigns of "Going to Love Lohas Life" and "Health Management of Breast Cancer Patients in China" have been held in Xi'an, Liaoning, Guangxi, Huaihua, Zhuzhou and other places.
In the next International Breast Cancer Care Month, there will be nearly 30 online and offline breast cancer prevention and control science popularization activities in various provinces and cities across the country.
(Finish)